Acne or acne vulgaris is a skin disease caused due to clogging of hair follicles with dead skin cells and oil from skin cells. This disease is characterized with pimples, blackheads, oily skin, and scarring. There are two types of acne-non-inflammatory and inflammatory acne, where the latter takes longer duration to heal and can cause permanent effects on the skin. Acne medications are either applied directly, which are present in formulations, or taken in the form of oral pills. These medications work by reducing inflammation and oil production. They also fight with bacteria finally preventing scarring. The common acne medications include retinoids, antibiotics, isotretinoin, benzoyl peroxide, and others. Research Beam Model: Research Beam Product ID: 3070506 5370 USD New
Acne Medication Market by Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others), Formulation (Topical Medications and Oral Medications), Type (Prescription Medicines and Over-The-Counter Medicines), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Grocery Stores, Pharmacies & Drug Stores, and e-Commerce) - Global Opportunity Analysis and Industry Forecast, 2017-2025
 
 

Acne Medication Market by Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others), Formulation (Topical Medications and Oral Medications), Type (Prescription Medicines and Over-The-Counter Medicines), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Grocery Stores, Pharmacies & Drug Stores, and e-Commerce) - Global Opportunity Analysis and Industry Forecast, 2017-2025

  • Category : Healthcare
  • Published On : May   2018
  • Pages : 290
  • Publisher : Allied Market Research
 
 
 

Acne or acne vulgaris is a skin disease caused due to clogging of hair follicles with dead skin cells and oil from skin cells. This disease is characterized with pimples, blackheads, oily skin, and scarring. There are two types of acne-non-inflammatory and inflammatory acne, where the latter takes longer duration to heal and can cause permanent effects on the skin. Acne medications are either applied directly, which are present in formulations, or taken in the form of oral pills. These medications work by reducing inflammation and oil production. They also fight with bacteria finally preventing scarring. The common acne medications include retinoids, antibiotics, isotretinoin, benzoyl peroxide, and others.

The global acne medication market was valued at $8,017 million in 2017, and is projected to reach $10,929 million by 2025 at a CAGR of 3.9% from 2018 to 2025. Increase in prevalence of acne diseases is the major factor that contributes toward the growth of the acne medication market. Moreover, other factors that fuel the market growth include unhealthy urban lifestyle, and presence of robust acne medications in pipeline. However, side-effects associated with the use of acne medications and presence of alternative treatment impede the market growth. Conversely, development of effective medications with lesser side effects and high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market growth.

The global acne medication market is segmented into therapeutic class, formulation, type, acne type, distribution channel, and region. Based on therapeutic class, the market is divided into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others. The retinoids segment is further classified into topical retinoid & combination retinoid and oral retinoid (isotretinoin). The antibiotics segment is further sub-segmented into topical antibiotics & combination antibiotics and oral antibiotics. Based on the formulation, the market is bifurcated into topical medication and oral medication. Based on type, the market is categorized into prescription medicine and over-the-counter (OTC) medicine. By acne type, the market is divided into non-inflammatory and inflammatory acne. The distribution channel covered in the study include grocery store, pharmacy & drug store, and e-commerce. Based on region, it is analyzed for across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global acne medication market with current trends and future estimations from 2017 to 2025 to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
  • Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key market segments

By Therapeutic Class

  • Retinoids
    • Topical Retinoid & Combination Retinoid
    • Oral Retinoid (Isotretinoin)
  • Antibiotics
    • Topical Antibiotic & Combination Antibiotics
    • Oral Antibiotics
  • Salicylic Acid
  • Benzoyl Peroxide
  • Others

By Formulation

  • Topical Medication
  • Oral Medication

By Type

  • Prescription Medicine
  • Over-the-counter (OTC) Medicine

By Acne Type

  • Inflammatory Acne
  • Non-inflammatory Acne

By Distribution Channel

  • Grocery Store
  • Pharmacy & Drug Store
  • e-Commerce

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Allergan Plc.
  • Nestle S.A.
  • Johnson & Johnson
  • Mayne Pharma Group Limited
  • Mylan N.V.
  • Pfizer Inc.
  • GlaxoSmithKline Plc
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

  • Daiichi Sankyo Company, Ltd.
  • Ranbaxy Laboratories Limited
  • Medicis Pharmaceutical Corporation
  • Foamix Pharmaceuticals
  • Prestium Pharma, Inc.
  • BioPharmX, Inc.

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. By Therapeutic Class
1.3.2. By Formulation
1.3.3. By Type
1.3.4. By Acne Type
1.3.5. By Distribution Channel
1.3.6. By Region
1.3.7. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Top player positioning, 2017
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in prevalence of acne diseases
3.4.1.2. Unhealthy urban lifestyle
3.4.1.3. Rise in focus on skin care products

3.4.2. Restraints

3.4.2.1. Side effects associated with acne medications
3.4.2.2. Presence of alternatives for acne treatment

3.4.3. Opportunities

3.4.3.1. Opportunities in emerging economies
3.4.3.2. Development of therapeutics with lesser side effects

3.4.4. Impact analyses

3.5. Clinical trials
3.6. Patent analysis (2013-2018)

3.6.1. Patent analysis, by year
3.6.2. Patent analysis for China, by year

CHAPTER 4: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

4.1. Overview

4.1.1. Market size and forecast

4.2. Retinoid

4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by type

4.2.2.1. Topical & combination retinoid

4.2.2.1.1. Market size and forecast, by region

4.2.2.2. Oral retinoid (Isotretinoin)

4.2.2.2.1. Market size and forecast, by region

4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country

4.3. Antibiotics

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type

4.3.2.1. Topical & combination antibiotics

4.3.2.1.1. Market size and forecast, by region

4.3.2.2. Oral antibiotics

4.3.2.2.1. Market size and forecast, by region

4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country

4.4. Salicylic acid

4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

4.5. Benzoyl Peroxide

4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

4.6. Other medications

4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country

CHAPTER 5: ACNE MEDICATION MARKET, BY FORMULATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Topical medications

5.2.1. Market size and forecast, by region

5.3. Oral medications

5.3.1. Market size and forecast, by region

CHAPTER 6: ACNE MEDICATION MARKET, BY TYPE

6.1. Overview

6.1.1. Market size and forecast

6.2. Prescription medicines

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Over-the-counter medicines

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

CHAPTER 7: ACNE MEDICATION MARKET, BY ACNE TYPE

7.1. Overview

7.1.1. Market size and forecast

7.2. Non-inflammatory acne

7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country

7.3. Inflammatory acne

7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country

CHAPTER 8: SOURCES: PRIMARY & SECONDARY RESEARCH AND AMR ANALYSIS ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

8.1. Overview

8.1.1. Market size and forecast

8.2. Grocery store

8.2.1. Market size and forecast, by region
8.2.2. Market analysis, by country

8.3. Pharmacy & drug store

8.3.1. Market size and forecast, by region
8.3.2. Market analysis, by country

8.4. e-Commerce

8.4.1. Market size and forecast, by region
8.4.2. Market analysis, by country

CHAPTER 9: ACNE MEDICATION MARKET, BY REGION

9.1. Overview

9.1.1. Market size and forecast

9.2. North America

9.2.1. Key market trends, growth factors and opportunities
9.2.2. North America acne medication market, by country

9.2.2.1. U.S.

9.2.2.1.1. Market size and forecast, by therapeutic class
9.2.2.1.2. Market size and forecast, by type
9.2.2.1.3. Market size and forecast, by acne type
9.2.2.1.4. Market size and forecast, by distribution channel

9.2.2.2. Canada

9.2.2.2.1. Market size and forecast, by therapeutic class
9.2.2.2.2. Market size and forecast, by type
9.2.2.2.3. Market size and forecast, by acne type
9.2.2.2.4. Market size and forecast, by distribution channel

9.2.2.3. Mexico

9.2.2.3.1. Market size and forecast, by therapeutic class
9.2.2.3.2. Market size and forecast, by type
9.2.2.3.3. Market size and forecast, by acne type
9.2.2.3.4. Market size and forecast, by distribution channel

9.2.3. North America market size and forecast, by therapeutic class
9.2.4. North America market size and forecast, by formulation
9.2.5. North America market size and forecast, by type
9.2.6. North America market size and forecast, by acne type
9.2.7. North America market size and forecast, by distribution channel

9.3. Europe

9.3.1. Key market trends, growth factors and opportunities
9.3.2. Europe market size and forecast, by country

9.3.2.1. Germany

9.3.2.1.1. Market size and forecast, by therapeutic class
9.3.2.1.2. Market size and forecast, by type
9.3.2.1.3. Market size and forecast, by acne type
9.3.2.1.4. Market size and forecast, by distribution channel

9.3.2.2. France

9.3.2.2.1. Market size and forecast, by therapeutic class
9.3.2.2.2. Market size and forecast, by type
9.3.2.2.3. Market size and forecast, by acne type
9.3.2.2.4. Market size and forecast, by distribution channel

9.3.2.3. UK

9.3.2.3.1. Market size and forecast, by therapeutic class
9.3.2.3.2. Market size and forecast, by type
9.3.2.3.3. Market size and forecast, by acne type
9.3.2.3.4. Market size and forecast, by distribution channel

9.3.2.4. Italy

9.3.2.4.1. Market size and forecast, by therapeutic class
9.3.2.4.2. Market size and forecast, by type
9.3.2.4.3. Market size and forecast, by acne type
9.3.2.4.4. Market size and forecast, by distribution channel

9.3.2.5. Spain

9.3.2.5.1. Market size and forecast, by therapeutic class
9.3.2.5.2. Market size and forecast, by type
9.3.2.5.3. Market size and forecast, by acne type
9.3.2.5.4. Market size and forecast, by distribution channel

9.3.3. Rest of Europe

9.3.3.1.1. Market size and forecast, by therapeutic class
9.3.3.1.2. Market size and forecast, by type
9.3.3.1.3. Market size and forecast, by acne type
9.3.3.1.4. Market size and forecast, by distribution channel

9.3.4. Europe market size and forecast, by therapeutic class
9.3.5. Europe market size and forecast, by formulation
9.3.6. Europe market size and forecast, by type
9.3.7. Europe market size and forecast, by acne type
9.3.8. Europe market size and forecast, by distribution channel

9.4. Asia-Pacific

9.4.1. Key market trends, growth factors and opportunities
9.4.2. Asia-Pacific market size and forecast, by country

9.4.2.1. Japan

9.4.2.1.1. Market size and forecast, by therapeutic class
9.4.2.1.2. Market size and forecast, by type
9.4.2.1.3. Market size and forecast, by acne type
9.4.2.1.4. Market size and forecast, by distribution channel

9.4.2.2. China

9.4.2.2.1. Market size and forecast, by therapeutic class
9.4.2.2.2. Market size and forecast, by type
9.4.2.2.3. Market size and forecast, by acne type
9.4.2.2.4. Market size and forecast, by distribution channel

9.4.2.3. India

9.4.2.3.1. Market size and forecast, by therapeutic class
9.4.2.3.2. Market size and forecast, by type
9.4.2.3.3. Market size and forecast, by acne type
9.4.2.3.4. Market size and forecast, by distribution channel

9.4.2.4. Australia

9.4.2.4.1. Market size and forecast, by therapeutic class
9.4.2.4.2. Market size and forecast, by type
9.4.2.4.3. Market size and forecast, by acne type
9.4.2.4.4. Market size and forecast, by distribution channel

9.4.2.5. South Korea

9.4.2.5.1. Market size and forecast, by therapeutic class
9.4.2.5.2. Market size and forecast, by type
9.4.2.5.3. Market size and forecast, by acne type
9.4.2.5.4. Market size and forecast, by distribution channel

9.4.2.6. Rest of Asia-Pacific

9.4.2.6.1. Market size and forecast, by therapeutic class
9.4.2.6.2. Market size and forecast, by type
9.4.2.6.3. Market size and forecast, by acne type
9.4.2.6.4. Market size and forecast, by distribution channel

9.4.3. Asia-Pacific market size and forecast, by therapeutic class
9.4.4. Asia-Pacific market size and forecast, by formulation
9.4.5. Asia-Pacific market size and forecast, by type
9.4.6. Asia-Pacific market size and forecast, by acne type
9.4.7. Asia-Pacific market size and forecast, by distribution channel

9.5. LAMEA

9.5.1. Key market trends, growth factors and opportunities
9.5.2. LAMEA market size and forecast, by country

9.5.2.1. Brazil

9.5.2.1.1. Market size and forecast, by therapeutic class
9.5.2.1.2. Market size and forecast, by type
9.5.2.1.3. Market size and forecast, by acne type
9.5.2.1.4. Market size and forecast, by distribution channel

9.5.2.2. Saudi Arabia

9.5.2.2.1. Market size and forecast, by therapeutic class
9.5.2.2.2. Market size and forecast, by type
9.5.2.2.3. Market size and forecast, by acne type
9.5.2.2.4. Market size and forecast, by distribution channel

9.5.2.3. South Africa

9.5.2.3.1. Market size and forecast, by therapeutic class
9.5.2.3.2. Market size and forecast, by type
9.5.2.3.3. Market size and forecast, by acne type
9.5.2.3.4. Market size and forecast, by distribution channel

9.5.2.4. Rest of LAMEA

9.5.2.4.1. Market size and forecast, by therapeutic class
9.5.2.4.2. Market size and forecast, by type
9.5.2.4.3. Market size and forecast, by acne type
9.5.2.4.4. Market size and forecast, by distribution channel

9.5.3. LAMEA market size and forecast, by therapeutic class
9.5.4. LAMEA market size and forecast, by formulation
9.5.5. LAMEA market size and forecast, by type
9.5.6. LAMEA market size and forecast, by acne type
9.5.7. LAMEA market size and forecast, by distribution channel

CHAPTER 10: COMPANY PROFILES

10.1. Allergan Plc

10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product portfolio
10.1.5. Business performance
10.1.6. Key strategic moves and developments

10.2. Nestle S.A. (Galderma S.A.)

10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Product portfolio
10.2.5. Business performance
10.2.6. Key strategic moves and developments

10.3. Johnson & Johnson

10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio
10.3.5. Business performance

10.4. Mayne Pharma Group Limited

10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product portfolio
10.4.5. Business performance
10.4.6. Key strategic moves and developments

10.5. Mylan N.V.

10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product portfolio
10.5.5. Business performance

10.6. Pfizer Inc.

10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product portfolio
10.6.5. Business performance
10.6.6.

10.7. GlaxoSmithKline Plc (Stiefel Laboratories, Inc.)

10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product portfolio
10.7.5. Business performance

10.8. Sun Pharmaceutical Industries Limited

10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Product portfolio
10.8.5. Business performance
10.8.6. Key strategic moves and developments

10.9. Teva Pharmaceutical Industries Ltd.

10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Business performance
10.9.6. Key strategic moves and developments

10.10. Valeant Pharmaceuticals International, Inc.

10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
10.10.5. Business performance
10.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 01. CLINICAL TRIALS COMPLETED IN THE WORLD, 2017
TABLE 02. GLOBAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 03. GLOBAL ACNE MEDICATION MARKET FOR RETINOID, BY TYPE, 2017-2025 ($MILLION)
TABLE 04. GLOBAL TOPICAL RETINOID & COMBINATION RETINOID MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 05. GLOBAL ORAL RETINOID (ISOTRETINOIN) MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 06. GLOBAL ACNE MEDICATION MARKET FOR RETINOID, BY REGION, 2017-2025 ($MILLION)
TABLE 07. GLOBAL ACNE MEDICATION MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2025 ($MILLION)
TABLE 08. GLOBAL TOPICAL ANTIBIOTICS & COMBINATION ANTIBIOTICS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 09. GLOBAL ORAL ANTIBIOTICS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 10. GLOBAL ANTIBIOTICS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 11. GLOBAL ACNE MEDICATION MARKET FOR SALICYLIC ACID, BY REGION, 2017-2025 ($MILLION)
TABLE 12. GLOBAL BENZOYL PEROXIDE MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 13. GLOBAL ACNE MEDICATION MARKET FOR OTHERS, BY REGION, 2017-2025 ($MILLION)
TABLE 14. GLOBAL ACNE MEDICATION MARKET, BY FORMULATION, 2017-2025 ($MILLION)
TABLE 15. GLOBAL TOPICAL MEDICATION MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 16. GLOBAL ORAL MEDICATION MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 17. GLOBAL ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 18. GLOBAL PRESCRIPTION BASED ACNE MEDICATION MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 19. GLOBAL OVER-THE-COUNTER ACNE MEDICATION MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 20. GLOBAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 21. GLOBAL ACNE MEDICATION MARKET FOR NON-INFLAMMATORY ACNE, BY REGION, 2017-2025 ($MILLION)
TABLE 22. GLOBAL ACNE MEDICATION MARKET FOR INFLAMMTORY ACNE, BY REGION, 2017-2025 ($MILLION)
TABLE 23. GLOBAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 24. GLOBAL ACNE MEDICATION MARKET FOR GROCERY SHOP, BY REGION, 2017-2025 ($MILLION)
TABLE 25. GLOBAL ACNE MEDICATION MARKET FOR PHARMACY & DRUG STORE, BY REGION, 2017-2025 ($MILLION)
TABLE 26. GLOBAL ACNE MEDICATION MARKET FOR E-COMMERCE, BY REGION, 2017-2025 ($MILLION)
TABLE 27. ACNE MEDICATION MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 28. NORTH AMERICA ACNE MEDICATION MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 29. U.S. ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 30. U.S. ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 31. U.S. ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 32. U.S. ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 33. CANADA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 34. CANADA ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 35. CANADA ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 36. CANADA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 37. MEXICO ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 38. MEXICO ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 39. MEXICO ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 40. MEXICO ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 41. NORTH AMERICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 42. NORTH AMERICA ACNE MEDICATION MARKET, BY FORMULATION, 2017-2025 ($MILLION)
TABLE 43. NORTH AMERICA ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 44. NORTH AMERICA ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 45. NORTH AMERICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 46. EUROPE ACNE MEDICATION MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 47. GERMANY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 48. GERMANY ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 49. GERMANY ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 50. GERMANY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 51. FRANCE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 52. FRANCE ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 53. FRANCE ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 54. FRANCE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 55. UK ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 56. UK ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 57. UK ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 58. UK ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 59. ITALY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 60. ITALY ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 61. ITALY ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 62. ITALY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 63. SPAIN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 64. SPAIN ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 65. SPAIN ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 66. SPAIN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 67. REST OF EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 68. REST OF EUROPE ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 69. REST OF EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 70. REST OF EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 71. EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 72. EUROPE ACNE MEDICATION MARKET, BY FORMULATION, 2017-2025 ($MILLION)
TABLE 73. EUROPE ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 74. EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 75. EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 76. ASIA-PACIFIC ACNE MEDICATION MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 77. JAPAN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 78. JAPAN ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 79. JAPAN ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 80. JAPAN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 81. CHINA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 82. CHINA ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 83. CHINA ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 84. CHINA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 85. INDIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 86. INDIA ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 87. INDIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 88. INDIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 89. AUSTRALIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 90. AUSTRALIA ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 91. AUSTRALIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 92. AUSTRALIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 93. SOUTH KOREA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 94. SOUTH KOREA ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 95. SOUTH KOREA ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 96. SOUTH KOREA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 97. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 98. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 99. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 100. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 101. ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 102. ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION, 2017-2025 ($MILLION)
TABLE 103. ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 104. ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 105. ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 106. LAMEA ACNE MEDICATION MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 107. BRAZIL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 108. BRAZIL ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 109. BRAZIL ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 110. BRAZIL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 111. SAUDI ARABIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 112. SAUDI ARABIA ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 113. SAUDI ARABIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 114. SAUDI ARABIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 115. SOUTH AFRICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 116. SOUTH AFRICA ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 117. SOUTH AFRICA ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 118. SOUTH AFRICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 119. REST OF LAMEA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 120. REST OF LAMEA ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 121. REST OF LAMEA ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 122. REST OF LAMEA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 123. LAMEA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 124. LAMEA ACNE MEDICATION MARKET, BY FORMULATION, 2017-2025 ($MILLION)
TABLE 125. LAMEA ACNE MEDICATION MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 126. LAMEA ACNE MEDICATION MARKET, BY ACNE TYPE, 2017-2025 ($MILLION)
TABLE 127. LAMEA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 128. ALLERGAN: COMPANY SNAPSHOT
TABLE 129. ALLERGEN: OPERATING SEGMENTS
TABLE 130. ALLERGAN: PRODUCT PORTFOLIO
TABLE 131. NESTL: COMPANY SNAPSHOT
TABLE 132. NESTL: OPERATING SEGMENTS
TABLE 133. NESTL: PRODUCT PORTFOLIO
TABLE 134. J&J: COMPANY SNAPSHOT
TABLE 135. J&J: OPERATING SEGMENTS
TABLE 136. J&J: PRODUCT PORTFOLIO
TABLE 137. MAYNE PHARMA: COMPANY SNAPSHOT
TABLE 138. MAYNE PHARMA: OPERATING SEGMENTS
TABLE 139. MAYNE PHARMA: PRODUCT PORTFOLIO
TABLE 140. MYLAN: COMPANY SNAPSHOT
TABLE 141. MYLAN: OPERATING SEGMENT
TABLE 142. MYLAN: PRODUCT PORTFOLIO
TABLE 143. PFIZER: COMPANY SNAPSHOT
TABLE 144. PFIZER: OPERATING SEGMENTS
TABLE 145. PFIZER: PRODUCT PORTFOLIO
TABLE 146. GSK: COMPANY SNAPSHOT
TABLE 147. GSK: OPERATING SEGMENTS
TABLE 148. GSK: PRODUCT PORTFOLIO
TABLE 149. SUN PHARMA: COMPANY SNAPSHOT
TABLE 150. SUN PHARMA: OPERATING SEGMENTS
TABLE 151. SUN PHARMA: PRODUCT PORTFOLIO
TABLE 152. TEVA: COMPANY SNAPSHOT
TABLE 153. TEVA: OPEARTING SEGMENT
TABLE 154. TEVA: PRODUCT PORTFOLIO
TABLE 155. VALEANT: COMPANY SNAPSHOT
TABLE 156. VALEANT.: OPERATING SEGMENTS
TABLE 157. VALEANT: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. ACNE MEDICATION MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018**
FIGURE 06. TOP PLAYER POSITIONING, 2017
FIGURE 07. AGE DISTRIBUTION OF ACNE PATEINTS IN U.S., 2013 (IN PERCENTAGE)
FIGURE 08. IMPACT ANALYSES
FIGURE 09. CLINICAL TRIALS IN ACNE MEDICATION MARKET, BY REGION, 2014-2018
FIGURE 10. PATENTS REGISTERED/APPROVED IN THE WORLD, 2013-2018
FIGURE 11. PATENTS ANALYSIS BY YEAR, 2013 THROUGH 2017
FIGURE 12. CHINA PATENT ANALYSIS, BY YEAR
FIGURE 13. COMPARATIVE ANALYSIS OF RETINOIDS MARKET, 2017 & 2025 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF ANTIBIOTICS MARKET, 2017 & 2025 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF SALICYLIC ACID MARKET, 2017 & 2025 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF BENZOYL PEROXIDE MARKET, 2017 & 2025 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF OTHER ACNE MEDICATIONS MARKET, 2017 & 2025 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF PRESCRIPTION MEDICINES MARKET, 2017 & 2025 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER MEDICINES MARKET, 2017 & 2025 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF ACNE MEDICATION MARKET FOR NON-INFLAMMATORY ACNE, 2017 & 2025 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF ACNE MEDICATION MARKET FOR INFLAMMATORY ACNE, 2017 & 2025 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS OF ACNE MEDICATION MARKET FOR GROCERY SHOP, 2017 & 2025 ($MILLION)
FIGURE 23. COMPARATIVE ANALYSIS OF ACNE MEDICATION MARKET FOR PHARMACY & DRUG STORE, 2017 & 2025 ($MILLION)
FIGURE 24. COMPARATIVE ANALYSIS OF ACNE MEDICATION MARKET FOR E-COMMERCE, 2017 & 2025 ($MILLION)
FIGURE 25. PERCENTAGE OF PEOPLE WHO SMOKE IN CANADA FROM 2010 TO 2014
FIGURE 26. ALLERGAN: NET SALES, 2015-2017 ($MILLION)
FIGURE 27. ALLERGAN: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)
FIGURE 28. NESTL: NET SALES, 2015-2017 ($MILLION)
FIGURE 29. NESTL: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)
FIGURE 30. NESTL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 31. J&J: NET SALES, 2015-2017 ($MILLION)
FIGURE 32. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 33. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 34. MAYNE PHARMA: NET SALES, 2015-2017 ($MILLION)
FIGURE 35. MAYNE PHARMA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36. MAYNE PHARMA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 37. MYLAN: NET SALES, 2015-2017 ($MILLION)
FIGURE 38. MYLAN: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)
FIGURE 39. MYLAN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 40. PFIZER: NET SALES, 2015-2017 ($MILLION)
FIGURE 41. PFIZER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 43. GSK: NET SALES, 2015-2017 ($MILLION)
FIGURE 44. GSK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 45. GSK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 46. SUN PHARMA: NET SALES, 2015-2017 ($MILLION)
FIGURE 47. SUN PHARMA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 48. SUN PHARMA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 49. TEVA: REVENUE, 2015-2017 ($MILLION)
FIGURE 50. TEVA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 51. TEVA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 52. VALEANT: REVENUE, 2015-2017 ($MILLION)
FIGURE 53. VALEANT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 54. VALEANT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

PURCHASE OPTIONS
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT